In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 0.08 below Bellevue Life Sciences Acquisition Corp average.

Within Medical Equipment & Supplies industry 185 other companies have achieved higher Quick Ratio than Bellevue Life Sciences Acquisition in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 3237 to 3812.

Explain Quick Ratio?
How much Cash & cash equivalents BLAC�s has?
What are BLAC�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BLAC/financial-strength

https://api.csimarket.com/api/v1/companies/BLAC/fundamentals

https://api.csimarket.com/api/v1/companies/BLAC/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

BLAC Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	33.19 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-37.16 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	0.08	Subscribe	Subscribe	Subscribe	Subscribe
BLAC's Total Ranking	# 3812	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	6.01 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	-8.76 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 186
Healthcare Sector	# 856
Overall Market	# 3812

Quick Ratio Statistics
High	Average	Low
1.71	0.22	0
(Dec 31 2021)		(Mar 31 2024)

Financial Statements
Bellevue Life Sciences Acquisition's Current Liabilities	$ 17 Millions	Visit BLAC's Balance sheet
Bellevue Life Sciences Acquisition's Cash & cash equivalent	$ 1 Millions	Visit BLAC's Balance sheet
Source of BLAC's Sales		Visit BLAC's Sales by Geography

Cumulative Bellevue Life Sciences Acquisition's Quick Ratio

BLAC's Quick Ratio for the trailling 12 Months

BLAC Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	50.84 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	13.12 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	0.1	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 4110	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	7.16 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-11.65 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to BLAC Financial Strength Comparisons >> Go to Compare BLAC Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2026 to $16.68 millions, cumulative Quick Ratio decreased to 0.1 above the BLAC average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 206 other companies have achieved higher Quick Ratio than Bellevue Life Sciences Acquisition. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3048 to 4110.

Explain Quick Ratio?
How much Cash & cash equivalents BLAC�s has?
What are BLAC�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 207
Healthcare Sector	# 911
Within the Market	# 4110

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.16	0.08	0.01
(Sep 30 2023)		(Mar 31 2024)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Cerus Corporation	0.20	$ 16.350 Millions	$ 80.006 Millions
Bioventus Inc	0.19	$ 30.709 Millions	$ 159.282 Millions
Nakamoto Inc	0.15	$ 19.420 Millions	$ 127.428 Millions
Dentsply Sirona Inc	0.15	$ 195.000 Millions	$ 1,312.000 Millions
National Vision Holdings Inc	0.15	$ 59.963 Millions	$ 405.705 Millions
Boston Scientific Corporation	0.13	$ 904.000 Millions	$ 7,150.000 Millions
Solventum Corporation	0.13	$ 451.000 Millions	$ 3,575.000 Millions
The Pennant Group Inc	0.12	$ 18.389 Millions	$ 151.730 Millions
Zimmer Biomet Holdings Inc	0.11	$ 399.900 Millions	$ 3,502.400 Millions
Bellevue Life Sciences Acquisition Corp	0.08	$ 1.368 Millions	$ 16.679 Millions
Integer Holdings Corporation	0.07	$ 14.135 Millions	$ 201.125 Millions
Solana Company	0.07	$ 1.129 Millions	$ 16.615 Millions
Vycor Medical Inc	0.04	$ 0.199 Millions	$ 5.107 Millions
Nuo Therapeutics Inc	0.03	$ 0.081 Millions	$ 2.455 Millions
3m Company	0.03	$ 322.000 Millions	$ 11,868.000 Millions
Enovis Corp	0.02	$ 13.038 Millions	$ 653.826 Millions
Stimcell Energetics Inc	0.02	$ 0.007 Millions	$ 0.383 Millions

Date modified: 2026-11-14T12:17:01+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.